Publications
49
Citations
916
Est. group size
~6
Recurring co-author estimate
Active years
14
Publishing since 2013
This researcher studies how gynecologic cancers, especially endometrial (uterine lining) cancer, develop at the molecular level, focusing on gene silencing, mutations, and signaling pathways such as PAX2, FOXA2, and VEGF-mTOR that drive precancerous changes into cancer. The work combines pathology, genomics, and molecular biology to identify markers that could help distinguish benign lesions from early cancers. Some publications also extend into related areas like ovarian and testicular cancer biology, immune cell signaling, and biomedical materials.
Publication output has been fairly steady over the past decade with moderate year-to-year fluctuation, showing a peak around 2022-2023 and averaging about 5 papers per year in the last five years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- A distinct mechanism of epigenetic reprogramming silences PAX2 and initiates endometrial carcinogenesis
Journal of Clinical Investigation · 2025
- Ru(II)‐Based Photo‐Antibiotics: Light‐Driven Eradication of Bacterial Biofilm and Rapid Healing of Infective Wounds in Wistar Rat
Chemistry - A European Journal · 2025
- Fbxw7 is a driver of uterine carcinosarcoma by promoting epithelial-mesenchymal transition
UNC Libraries · 2025
- β-catenin, PAX2, and PTEN Aberrancy Across the Spectrum of Endometrioid Ovarian Lesions
International Journal of Gynecological Pathology · 2024
- Demystifying AI-enabled Information Systems for Smarter Business Decisions
Paradigm A Management Research Journal · 2024
- PAX2 is Transcriptionally Silenced by a Distinct Mechanism of Epigenetic Reprogramming to Initiate Endometrial Carcinogenesis
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- β-catenin, Pax2, and Pten Panel Identifies Precancers Among Histologically Subdiagnostic Endometrial Lesions
The American Journal of Surgical Pathology · 2023
- β-Catenin, PAX2 and PTEN panel in the diagnosis of endometrial precancers: a case-based review
Diagnostic histopathology · 2023
- Endometrial Polyps—Are They Characterized by HMGA Rearrangements or Not? Reply to Bullerdiek et al.
Modern Pathology · 2023
- Loss of liver kinase B1 in human seminoma
Frontiers in Oncology · 2023
- Data from Adipose-Derived VEGF–mTOR Signaling Promotes Endometrial Hyperplasia and Cancer: Implications for Obese Women
2023
- Figure S1-S3, Table S1-S3 from Adipose-Derived VEGF–mTOR Signaling Promotes Endometrial Hyperplasia and Cancer: Implications for Obese Women
2023
- Data from Adipose-Derived VEGF–mTOR Signaling Promotes Endometrial Hyperplasia and Cancer: Implications for Obese Women
2023
- Figure S1-S3, Table S1-S3 from Adipose-Derived VEGF–mTOR Signaling Promotes Endometrial Hyperplasia and Cancer: Implications for Obese Women
2023
- FOXA2 suppresses endometrial carcinogenesis and epithelial-mesenchymal transition by regulating enhancer activity
Journal of Clinical Investigation · 2022
- bioRxiv (Cold Spring Harbor Laboratory)×4
- Journal of Clinical Investigation×2
- Oncotarget×2
- Modern Pathology×2
- Journal of Biosciences×2
- Corinne Calo
Medicine · The Ohio State University
- David E. Cohn
Medicine · The Ohio State University
- Adrian A. Suarez
Medicine · The Ohio State University
- Casey Cosgrove
Medicine · The Ohio State University
- Floor Backes
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile